Research & Development



  雲瑯眨巴眨巴眼楮道︰“微臣此生不願意與陛下為敵!”   雲瑯拱手道︰“貴人依舊艷光四射,何來老婦之說?”曰本高清一本道无码av   這座城市從他誕生的第一天開始,就注定了他是一座以商貿為主的城池。52avav我爱aⅴ在线观看   阿嬌聞言大笑道︰“現在是不是只有你還把我當成女人來看?這可是老婦今年听到的最讓人歡喜的一句話。”   “你兩個兒子改姓為吳,到了下邳城,有一些不多的家業餓不死,也算不上富貴,長大倒是沒有問題。倒是你老婆似乎有些不甘寂寞,在到達下邳城的第二天就背著包袱跟一個人跑了。”亚洲人妻av伦理   果然,人依舊是那個人沒有變化。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo